See more : CERo Therapeutics Holdings, Inc. (CEROW) Income Statement Analysis – Financial Results
Complete financial analysis of Healthwell Acquisition Corp. I (HWELU) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Healthwell Acquisition Corp. I, a leading company in the Shell Companies industry within the Financial Services sector.
- Veranda Learning Solutions Limited (VERANDA.BO) Income Statement Analysis – Financial Results
- GT Group Holdings Limited (0263.HK) Income Statement Analysis – Financial Results
- Webzen Inc. (069080.KQ) Income Statement Analysis – Financial Results
- Rail Vision Ltd. (RVSN) Income Statement Analysis – Financial Results
- Xiamen Comfort Science&Technology Group Co., Ltd (002614.SZ) Income Statement Analysis – Financial Results
Healthwell Acquisition Corp. I (HWELU)
Industry: Shell Companies
Sector: Financial Services
About Healthwell Acquisition Corp. I
Healthwell Acquisition Corp. I does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to acquire technology-enabled companies in the healthcare industry. The company was incorporated in 2021 and is based in Winnetka, Illinois.
| Metric | 2022 | 2021 |
|---|---|---|
| Revenue | 0.00 | 0.00 |
| Cost of Revenue | 1.42M | 0.00 |
| Gross Profit | -1.42M | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 |
| SG&A | 1.42K | 602.87 |
| Other Expenses | 1.62M | -735.10K |
| Operating Expenses | 1.62M | 4.90K |
| Cost & Expenses | 1.62M | 4.90K |
| Interest Income | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 |
| Depreciation & Amortization | -13.80M | 5.23M |
| EBITDA | -15.42M | 5.70K |
| EBITDA Ratio | 0.00% | 0.00% |
| Operating Income | -1.62M | -801.93 |
| Operating Income Ratio | 0.00% | 0.00% |
| Total Other Income/Expenses | 13.80M | 5.70K |
| Income Before Tax | 12.17M | 4.90K |
| Income Before Tax Ratio | 0.00% | 0.00% |
| Income Tax Expense | 758.88K | -5.23M |
| Net Income | 11.41M | 4.90K |
| Net Income Ratio | 0.00% | 0.00% |
| EPS | 0.46 | 0.28 |
| EPS Diluted | 0.46 | 0.28 |
| Weighted Avg Shares Out | 25.00M | 17.24K |
| Weighted Avg Shares Out (Dil) | 25.00M | 17.24K |
U.S. IPO Weekly Recap: Postponements Abound In A 4 IPO Week
Source: https://incomestatements.info
Category: Stock Reports